Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis
Status:
Withdrawn
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The MUSIC OL study is an open-label extension study, in which all eligible patients having
completed the double-blind AC-055B201/MUSIC study as scheduled receive macitentan 10 mg once
daily. The study objective is to assess the long-term safety and tolerability of macitentan
in patients with idiopathic pulmonary fibrosis (IPF).